Opaleye Management Inc. Iovance Biotherapeutics, Inc. Transaction History
Opaleye Management Inc.
- $390 Million
- Q2 2024
A detailed history of Opaleye Management Inc. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Opaleye Management Inc. holds 897,000 shares of IOVA stock, worth $8.98 Million. This represents 1.84% of its overall portfolio holdings.
Number of Shares
897,000
Previous 897,000
-0.0%
Holding current value
$8.98 Million
Previous $13.3 Million
45.89%
% of portfolio
1.84%
Previous 3.23%
Shares
5 transactions
Others Institutions Holding IOVA
# of Institutions
323Shares Held
239MCall Options Held
1.27MPut Options Held
1.68M-
Vanguard Group Inc Valley Forge, PA26MShares$260 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY25.9MShares$260 Million6.02% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$240 Million28.39% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$212 Million0.0% of portfolio
-
State Street Corp Boston, MA12.6MShares$126 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.58B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...